[1] Cecic I,Stott B,Sun J,et al.Relevance of innate immunity recognition of altered self in the induction of host response associated with photodynamic therapy[J].Recent Res Dev Cancer,2004,6:153-161.

[2] Korbelik M,Sun J,Cecic I.Photodynamie therapy-induced cell surface expression and release of heat shock proteins:relevancefor tumor response[J].Cancer Res,2005,65:1026-1028.

[3] Jalili A,Makowski M,Switaj T,et al.Effective photoimmu-notherapy ofmurine colon carcinoma induced by the combi-nation of photodynamic therapy and dendritic cells[J].Clin Cancer Res,2004,10:4498-4508.

[4] Korbelik M.Role of Toll-like receptors in photodynamie therapy-elicited host response[J].Proc SHE,2004,5319:39-77

[5] Stott B,Korbelik M.Activation of complement C3,C5,C9 genes in tumors treated by photodynamic therapy[J].Cane-or Immunol Immunother.2007,56:649-658.

[6] Korbelik M,Cecic I.Enhancement of tumour response to photodynamic therapy bY adjuvant mycobacterium cell-wall treatment[J].J Photochem Photobiol B,1998,44:151-158.

[7] Korbelik M,Sun J,Posakony JJ.Interaction between pho-todynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors[J].Photo-chem Photobiol,2001,73:403-409.

[8] Cecic I,Korbelik M.Deposition of complement proteins on cells treated by photodynamic therapy in vitro[J].J Environ Pathol Toxicol Oncol,2006,25:189-204.

[9] Korbelik M,Merchant S,Sun J,et al.Acute phase response induced following tumor treatment by photedynamic thera-Py:relevance for the therapy outcome[J].Proc SPIE,2006,6087:73-79.

[10] Korbelik M.PDT-associated host response and its role in the therapy outcome[J].Lagers Surg Med,2006,38:500-508.

[11] Cecic I,Korbelik M.Mediators of peripheral blood neu-trophilia induced by photodynamic therapy of solid tumors[J].Cancer Lett,2002,183:43-51.

[12] Gollnick SO,Evans SS,Baumann H,et al.Role of cyto-kines in photodynamic therapy-induced local and systemic inflammation[J].Br J Cancer,2003,88:1772-1779.

[13] Krosl G,Korbelik M,Dongherty GJ.Induction of immune cell infiltration into murine SCCV II tumour by Photofrin-based photodynamic therapy[J].Br J Cancer,1995,71:549-555.

[14] Gollnick SO,Liu X,Owczarezak B,et al.Altered ex-pression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo[J].Cancer Res,1997,57:3904-3909.

[15] Cecic I,Parkins CS,Korbelik M.Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors[J].Photochem Photobiol,2001,74:712-720.

[16] Sun J,CecicI,Parkins CS,etal.Neutrophils as inflam-matory and immune effectors in photodynamie therapy-treated mouse SCCV Ⅱ tumours[J].Photochem Photobi-ol Sci,2002,1:690-695.

[17] Korbelik M,Sun J,Cecic I,et al.Adjuvant treatment for complement activation increases the effectiveness of photo-dynamic therapy of solid tumors[J].Photochem Photobi-ol Sci,2004,3:812-816.

[18] Cecic I,Serrano K,Gyongyossy-Issa M,et al.Characteris-tics of complement activation in mice bearing Lewis lung carcinomas treated by photedynamic therapy[J].Cancer Lett,2005,225:215-223.

[19] Cecic I,Sun J,Korbelik M.Role of complement anaphy-latoxin C3a in PDT-elicited engagement of host neutrophils and other immune cells[J].Photochem Photobiol,2006,82:558-562.

[20] Korbelik M,Cooper PD.Potentiation of photodynamic ther-apy of cancer by complement:the effect of gamma-inulin[J].Br J Cancer,2007,96:67-72.

[21] Cecic I,Stott B,Korbelik M.Acute phase response-asso-ciated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy[J].Int Immunop-harmaeol,2006,6:1259-1266.

[22] de Vree WJ,Essers MC,de Bmijn HS,et al.Evidence for all important role of neutrophils in the efficacy of pho-todynamic therapy in vivo[J].Cancer Res,1996,56:2908-2911.

[23] Korbelik M,Cecic I.Contribution of myeloid and lymph-oid host ceHs to the curative outcome of moRse sarcoma treatment by photodynamie therapy[J].Cancer Lett,1999,137:91-98.

[24] Bellnier DA.Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-Mpha[J].J Photochem Photobiol B,1991,8:203-210.

[25] Golab J,Wilczynski G,Zagozdzon R.et al.Potentiation of the anti-tumor effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF[J].Br J Canc-er,2000,82:1485-1491.

[26] Reiter I,Schwamberger G,Krammer B.Activation of mac-rophage tumoricidal acfivity by photodynamic treatment in vitro-indirect activation of macrophages by photodynami-cally killed tumor cells[J].J Photochem Photobiol B,1999,50:99-107.

[27] Korbelik M,Naraparaju VR,Yamamoto N.Macrophage-di-rocted immunotherapy as adjuvant to photodynamic thera-py of cancer[J].Br J Cancer,1997,75:202-207.

[28] Ferrario A,Fisher AM,Rucker N,et al.Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and ansio-genie factors[J].Cancer Res,2005,65:9473-9478.

[29] Gollnick SO,Vanghan L,Henderson BW.Generation of effective antitumor vaccines using photodynamic therapy[J].Cancer Res,2002,62:1604-1608.

[30] Korbelik M,Sun J.PDT-generated vaccine for cancer therapy[J].Cancer Immunol Immuother,2006,55:900-909.

[31] Gollnick SO,Owczarczak B,Maiter P.PDT and anti-tumor immunity[J].Lasers Surg Med,2006,38:509-515.

[32] Hendrzak-Henion JA,Knisely TL,Cincotta L,et al.Role of the immune system in mediating the antitumor effect of benzophenothiazine photod3,nanlie therapy[J].Photochem Photobiol,1999,69:575-581.

[33] Korbelik M,Dougherty GJ.Photodynamic therapy-medi-ated immune response against subcutaneous mouse tnnlors[J].Cancer Res,1999,59:1941-1946.

[34] Korbelik M,Krosl G,Krosl J,et al.The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy[J].Cancer Res,1996,56:5647-5652.